Investing.com – Compugen (NASDAQ: ) reported third quarter EPS of $0.010, $0.11 better than the analyst estimate of $-0.100. Revenue for the quarter came in at $17.13M versus the consensus estimate of $1.66M.
Compugen’s stock price closed at $1.74. It is down -5.430% in the last 3 months and up 228.300% in the last 12 months.
Compugen saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Compugen’s stock price’s past reactions to earnings here.
According to InvestingPro, Compugen’s Financial Health score is “great performance“.
Check out Compugen’s , and Compugen’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
